Massimo Calafiore's most recent trade in Orthofix Medical Inc was a trade of 10,000 Common Stock done at an average price of $12.5 . Disclosure was reported to the exchange on May 9, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Orthofix Medical Inc | Massimo Calafiore | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 12.54 per share. | 09 May 2025 | 10,000 | 234,603 (1%) | 0% | 12.5 | 125,400 | Common Stock |
Orthofix Medical Inc | Massimo Calafiore | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 17.43 per share. | 05 Mar 2025 | 9,914 | 222,404 (1%) | 0% | 17.4 | 172,801 | Common Stock |
Orthofix Medical Inc | Massimo Calafiore | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 209,541 | 209,541 | - | - | Employee Stock Option (Right to Buy) | |
Orthofix Medical Inc | Massimo Calafiore | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 88,339 | 212,490 (1%) | 0% | 0 | Common Stock | |
Orthofix Medical Inc | Massimo Calafiore | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 10 Jan 2025 | 10,078 | 133,354 (0%) | 0% | 16.8 | 169,619 | Common Stock |
Orthofix Medical Inc | Massimo Calafiore | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 17.14 per share. | 10 Jan 2025 | 9,203 | 124,151 (0%) | 0% | 17.1 | 157,757 | Common Stock |
Orthofix Medical Inc | Calafiore Massimo | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 392,005 | 392,005 | - | - | Employee Stock Option (right to buy) | |
Orthofix Medical Inc | Massimo Calafiore | President & CEO | Grant, award, or other acquisition of securities at price $ 13.29 per share. | 08 Jan 2024 | 141,084 | 141,084 (0%) | 0% | 13.3 | 1,875,006 | Common Stock |